Mrv1909 01032022002D 8 8 0 0 0 0 999 V2000 -1.7587 -0.4034 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.7587 0.1486 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.3065 -0.6334 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.3609 -0.1484 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 0.1059 0.6362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7190 0.6362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.9740 -0.1484 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.1456 -0.4034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 7 2 0 0 0 0 2 8 2 0 0 0 0 3 4 1 0 0 0 0 3 7 1 0 0 0 0 4 5 1 0 0 0 0 4 8 1 1 0 0 0 5 6 1 0 0 0 0 6 7 1 0 0 0 0 M END > DB03901 > drugbank > O=C[C@@H]1CCC(=O)N1 > InChI=1S/C5H7NO2/c7-3-4-1-2-5(8)6-4/h3-4H,1-2H2,(H,6,8)/t4-/m0/s1 > XBGYMVTXOUKXLG-BYPYZUCNSA-N > C5H7NO2 > 113.1146 > 113.047678473 > 2 > 15 > -1.7909741847402505e-05 > 10.703649453301786 > 1 > 1 > 0 > 0 > (2S)-5-oxopyrrolidine-2-carbaldehyde > -1.0482859546666667 > 0 > 0 > 1 > 0 > 18.626158155028453 > 11.746885361057299 > -2.139371482525064 > 46.17 > 27.162399999999998 > 1 > 1 > (2S)-2-({4-[(2E)-N-({2-amino-4-oxo-1H-pyrido[3,2-d]pyrimidin-6-yl}methyl)-3-{5-carbamoyl-3-[(2R,3R,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]imidazol-4-yl}prop-2-enamido]phenyl}formamido)pentanedioic acid > 0 > DB03901 > EXPT00900 > experimental > 5-Oxoprolinal > (2S)-5-Oxo-2-pyrrolidinecarbaldehyde; 5-Ketoprolinal $$$$